{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:40Z","timestamp":1792813240020,"version":"4.5.0"},"reference-count":167,"publisher":"Annual Reviews","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,23]]},"abstract":"<jats:p>\n                    Malaria remains a major global health burden despite decades of effort toward its prevention and treatment. Much of this difficulty stems from the complexity of the\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    parasite's life cycle and its interactions with the human host. Here, we review receptor\u2013ligand interactions between the\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    parasite and human host, with a focus on clinically relevant antigens. The parasite uses a variety of proteins at each stage of its life cycle to achieve requisite functions such as motility, cell traversal, and invasion. In turn, the human immune response targets these key parasite antigens, and we review well-characterized antibody\u2013antigen interactions. Finally, we describe several mechanisms the parasite uses to evade the human immune response. Understanding of this evolutionary back-and-forth has inspired several different vaccines and therapeutics, and we describe ongoing efforts to create improved next-generation versions.\n                  <\/jats:p>","DOI":"10.1146\/annurev-micro-042424-032639","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:41:15Z","timestamp":1781307675000},"page":"37-60","source":"Crossref","is-referenced-by-count":0,"title":["Host\u2013Pathogen Interactions in Malaria: Invasion, Neutralization, and Evasion"],"prefix":"10.1146","volume":"80","author":[{"given":"Thayne H.","family":"Dickey","sequence":"first","affiliation":[{"name":"Host\u2013Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA ; email: niraj.tolia@nih.gov"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj H.","family":"Tolia","sequence":"additional","affiliation":[{"name":"Host\u2013Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA ; email: niraj.tolia@nih.gov"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"112681","DOI":"10.1016\/j.celrep.2023.112681","article-title":"Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection","volume":"42","year":"2023","journal-title":"Cell Rep"},{"key":"B2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/imcb.12320","article-title":"Antibody effector functions in malaria and other parasitic diseases: a few needles and many haystacks","volume":"98","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","year":"2019","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41564-018-0254-z","article-title":"Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin","volume":"3","year":"2018","journal-title":"Nat. Microbiol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood-2018-07-865451","article-title":"Human erythrocyte band 3 is a host receptor for Plasmodium falciparum glutamic acid\u2013rich protein","volume":"133","year":"2019","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1038\/s41467-024-50770-7","article-title":"A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood.2023020831","article-title":"Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion","volume":"142","year":"2023","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.cell.2024.06.015","article-title":"Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype","volume":"187","year":"2024","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"crossref","first-page":"e1003869","DOI":"10.1371\/journal.ppat.1003869","article-title":"Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC","volume":"10","year":"2014","journal-title":"PLOS Pathog"},{"key":"B10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nsmb.2088","article-title":"Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC","volume":"18","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.immuni.2025.09.014","article-title":"Cryo-EM structure of endogenous Pfs230:Pfs48\/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activity","volume":"58","year":"2025","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"crossref","first-page":"e12294","DOI":"10.1371\/journal.pone.0012294","article-title":"Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei","volume":"5","year":"2010","journal-title":"PLOS ONE"},{"key":"B13","doi-asserted-by":"crossref","first-page":"e1000309","DOI":"10.1371\/journal.ppat.1000309","article-title":"Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion","volume":"5","year":"2009","journal-title":"PLOS Pathog"},{"key":"B14","doi-asserted-by":"crossref","first-page":"e1010409","DOI":"10.1371\/journal.ppat.1010409","article-title":"A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum","volume":"18","year":"2022","journal-title":"PLOS Pathog"},{"key":"B15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.180.1.389","article-title":"Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein","volume":"180","year":"1994","journal-title":"J. Exp. Med."},{"key":"B16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-020-0160-2","article-title":"Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial","volume":"5","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B17","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.mib.2025.102598","article-title":"Immune evasion runs in the family: two surface protein families of Plasmodium falciparum\u2013infected erythrocytes","volume":"85","year":"2025","journal-title":"Curr. Opin. Microbiol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1172\/JCI62182","article-title":"Targets of antibodies against Plasmodium falciparum\u2013infected erythrocytes in malaria immunity","volume":"122","year":"2012","journal-title":"J. Clin. Investig."},{"key":"B19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/s41467-021-21811-2","article-title":"Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b","volume":"12","year":"2021","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"crossref","first-page":"108996","DOI":"10.1016\/j.celrep.2021.108996","article-title":"Avid binding by B cells to the Plasmodium circumsporozoite protein repeat suppresses responses to protective subdominant epitopes","volume":"35","year":"2021","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"crossref","first-page":"e1003390","DOI":"10.1371\/journal.ppat.1003390","article-title":"Structural and functional basis for inhibition of erythrocyte invasion by antibodies that target Plasmodium falciparum EBA-175","volume":"9","year":"2013","journal-title":"PLOS Pathog"},{"key":"B22","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1073\/pnas.1600488113","article-title":"Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein","volume":"113","year":"2016","journal-title":"PNAS"},{"key":"B23","doi-asserted-by":"crossref","first-page":"e21347","DOI":"10.7554\/eLife.21347","article-title":"Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA","volume":"6","year":"2017","journal-title":"eLife"},{"key":"B24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03378-6","article-title":"Structural basis of malaria RIFIN binding by LILRB1-containing antibodies","volume":"592","year":"2021","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.vaccine.2018.08.033","article-title":"Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: a Phase 1 dose-escalation study in healthy adults","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pt.2008.07.005","article-title":"Mutually exclusive var gene expression in the malaria parasite: multiple layers of regulation","volume":"24","year":"2008","journal-title":"Trends Parasitol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41467-021-21955-1","article-title":"A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes","volume":"12","year":"2021","journal-title":"Nat. Commun."},{"key":"B28","first-page":"1308","article-title":"Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody","volume":"3","year":"2007","journal-title":"PLOS Pathog"},{"key":"B29","doi-asserted-by":"crossref","first-page":"e1003258","DOI":"10.1371\/journal.ppat.1003258","article-title":"The secret life of viral entry glycoproteins: moonlighting in immune evasion","volume":"9","year":"2013","journal-title":"PLOS Pathog"},{"key":"B30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20101488","article-title":"The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host","volume":"208","year":"2011","journal-title":"J. Exp. Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"eadr0510","DOI":"10.1126\/science.adr0510","article-title":"Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein","volume":"387","year":"2025","journal-title":"Science"},{"key":"B32","doi-asserted-by":"crossref","first-page":"114012","DOI":"10.1016\/j.celrep.2024.114012","article-title":"The essential malaria protein PfCyRPA targets glycans to invade erythrocytes","volume":"43","year":"2024","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41541-021-00366-9","article-title":"Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes","volume":"6","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41541-023-00619-9","article-title":"Design of a stabilized non-glycosylated Pfs48\/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B35","doi-asserted-by":"crossref","first-page":"e5095","DOI":"10.1002\/pro.5095","article-title":"Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes","volume":"33","year":"2024","journal-title":"Protein Sci"},{"key":"B36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pt.2023.06.011","article-title":"Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein","volume":"39","year":"2023","journal-title":"Trends Parasitol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"eady0241","DOI":"10.1126\/science.ady0241","article-title":"Cryo-EM structure of endogenous Plasmodium falciparum Pfs230 and Pfs48\/45 fertilization complex","volume":"389","year":"2025","journal-title":"Science"},{"key":"B38","doi-asserted-by":"crossref","first-page":"eabg0465","DOI":"10.1126\/sciadv.abg0465","article-title":"Structure of the merozoite surface protein 1 from Plasmodium falciparum","volume":"7","year":"2021","journal-title":"Sci. Adv."},{"key":"B39","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1073\/pnas.1205737109","article-title":"Unexpected fold in the circumsporozoite protein target of malaria vaccines","volume":"109","year":"2012","journal-title":"PNAS"},{"key":"B40","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41467-019-09894-4","article-title":"A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.1719660115","article-title":"Alpha-v\u2013containing integrins are host receptors for the Plasmodium falciparum sporozoite surface protein, TRAP","volume":"115","year":"2018","journal-title":"PNAS"},{"key":"B42","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites","volume":"100","year":"2003","journal-title":"PNAS"},{"key":"B43","doi-asserted-by":"crossref","first-page":"e1002725","DOI":"10.1371\/journal.ppat.1002725","article-title":"Shedding of TRAP by a rhomboid protease from the malaria sporozoite surface is essential for gliding motility and sporozoite infectivity","volume":"8","year":"2012","journal-title":"PLOS Pathog"},{"key":"B44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/genetics\/149.1.189","article-title":"Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum","volume":"149","year":"1998","journal-title":"Genetics"},{"key":"B45","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","year":"2013","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2023.01.009","article-title":"Highly potent, naturally acquired human monoclonal antibodies against Pfs48\/45 block Plasmodium falciparum transmission to mosquitoes","volume":"56","year":"2023","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-023-06856-1","article-title":"The PfRCR complex bridges malaria parasite and erythrocyte during invasion","volume":"625","year":"2024","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"crossref","first-page":"e20383","DOI":"10.7554\/eLife.20383","article-title":"Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody","volume":"6","year":"2017","journal-title":"eLife"},{"key":"B49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pt.2008.09.012","article-title":"Plasmodium vivax and the importance of the subtelomeric multigene vir superfamily","volume":"25","year":"2009","journal-title":"Trends Parasitol"},{"key":"B50","first-page":"a025551","article-title":"Malaria during pregnancy. Cold Spring Harb","volume":"7","year":"2017","journal-title":"Perspect. Med."},{"key":"B51","doi-asserted-by":"crossref","first-page":"e4852","DOI":"10.1002\/pro.4852","article-title":"Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain","volume":"33","year":"2024","journal-title":"Protein Sci"},{"key":"B52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.chom.2011.10.012","article-title":"Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by Apicomplexa","volume":"10","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-018-0249-1","article-title":"Cryo-EM structure of an essential Plasmodium vivax invasion complex","volume":"559","year":"2018","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41541-025-01262-2","article-title":"A combined designed CSP and Pfs48\/45 infection and transmission blocking vaccine for malaria","volume":"10","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B55","first-page":"2539","article-title":"Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5","volume":"16","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"B56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-020-2530-3","article-title":"Structural basis for RIFIN-mediated activation of LILRB1 in malaria","volume":"587","year":"2020","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/iai.65.8.3017-3023.1997","article-title":"Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230","volume":"65","year":"1997","journal-title":"Infect. Immun."},{"key":"B58","doi-asserted-by":"crossref","first-page":"e146221","DOI":"10.1172\/JCI146221","article-title":"Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice","volume":"131","year":"2021","journal-title":"J. Clin. Investig."},{"key":"B59","first-page":"EVIDoa2400188","article-title":"A vaccine to block Plasmodium falciparum transmission","volume":"4","year":"2025","journal-title":"NEJM Evid"},{"key":"B60","doi-asserted-by":"crossref","first-page":"eadf1782","DOI":"10.1126\/scitranslmed.adf1782","article-title":"Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection","volume":"15","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s42003-022-03688-z","article-title":"Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages","volume":"5","year":"2022","journal-title":"Commun. Biol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.aar5304","article-title":"Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope","volume":"360","year":"2018","journal-title":"Science"},{"key":"B63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41541-023-00784-x","article-title":"Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.immuni.2023.01.013","article-title":"Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230","volume":"56","year":"2023","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/imr.12807","article-title":"Cerebral Plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it","volume":"293","year":"2020","journal-title":"Immunol. Rev."},{"key":"B66","doi-asserted-by":"crossref","first-page":"e20621","DOI":"10.7554\/eLife.20621","article-title":"Malaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption","volume":"5","year":"2016","journal-title":"eLife"},{"key":"B67","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2958.2005.05024.x","article-title":"CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts","volume":"59","year":"2006","journal-title":"Mol. Microbiol."},{"key":"B68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.1827210","article-title":"Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein","volume":"252","year":"1991","journal-title":"Science"},{"key":"B69","doi-asserted-by":"crossref","first-page":"101654","DOI":"10.1016\/j.xcrm.2024.101654","article-title":"Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies","volume":"5","year":"2024","journal-title":"Cell Rep. Med."},{"key":"B70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","year":"2018","journal-title":"Nat. Med."},{"key":"B71","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.jbc.2022.102241","article-title":"Implications of conformational flexibility, lipid binding, and regulatory domains in cell-traversal protein CelTOS for apicomplexan migration","volume":"298","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41541-025-01140-x","article-title":"Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens","volume":"10","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B74","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1073\/pnas.1911792117","article-title":"Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform","volume":"117","year":"2020","journal-title":"PNAS"},{"key":"B75","doi-asserted-by":"crossref","first-page":"e2215003120","DOI":"10.1073\/pnas.2215003120","article-title":"The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway","volume":"120","year":"2023","journal-title":"PNAS"},{"key":"B76","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41467-018-06340-9","article-title":"Structural basis for recognition of the malaria vaccine candidate Pfs48\/45 by a transmission blocking antibody","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"key":"B77","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1074\/jbc.M115.698282","article-title":"Multiple Plasmodium falciparum merozoite surface protein 1 complexes mediate merozoite binding to human erythrocytes","volume":"291","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B78","doi-asserted-by":"crossref","first-page":"36830","DOI":"10.1074\/jbc.M112.409276","article-title":"Crystal and solution structures of Plasmodium falciparum erythrocyte-binding antigen 140 reveal determinants of receptor specificity during erythrocyte invasion","volume":"287","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-024-00819-x","article-title":"Establishing RTS,S\/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model","volume":"9","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/CVI.00501-15","article-title":"Acquisition and longevity of antibodies to Plasmodium vivax preerythrocytic antigens in western Thailand","volume":"23","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"B81","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1038\/srep11820","article-title":"Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates","volume":"5","year":"2015","journal-title":"Sci. Rep."},{"key":"B82","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/IAI.01021-10","article-title":"Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites","volume":"79","year":"2011","journal-title":"Infect. Immun."},{"key":"B83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41541-023-00653-7","article-title":"Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41564-020-00858-9","article-title":"Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA","volume":"6","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B85","doi-asserted-by":"crossref","first-page":"e1011879","DOI":"10.1371\/journal.ppat.1011879","article-title":"Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine","volume":"20","year":"2024","journal-title":"PLOS Pathog"},{"key":"B86","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1074\/jbc.M113.450643","article-title":"Molecular basis for sialic acid-dependent receptor recognition by the Plasmodium falciparum invasion protein erythrocyte-binding antigen-140\/BAEBL","volume":"288","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B87","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41467-023-40151-x","article-title":"Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection","volume":"14","year":"2023","journal-title":"Nat. Commun."},{"key":"B88","doi-asserted-by":"crossref","first-page":"39462","DOI":"10.1038\/srep39462","article-title":"Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1","volume":"6","year":"2016","journal-title":"Sci. Rep."},{"key":"B89","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.immuni.2022.07.015","article-title":"Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody responses","volume":"55","year":"2022","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1038\/s41467-019-11980-6","article-title":"Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"B91","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chom.2020.07.001","article-title":"Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response","volume":"28","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B92","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","year":"2021","journal-title":"Med"},{"key":"B93","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/IAI.01056-13","article-title":"Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay","volume":"81","year":"2013","journal-title":"Infect. Immun."},{"key":"B94","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","article-title":"First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria","volume":"69","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/jmbi.1999.2753","article-title":"Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1","volume":"289","year":"1999","journal-title":"J. Mol. Biol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41467-023-39357-w","article-title":"Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax","volume":"14","year":"2023","journal-title":"Nat. Commun"},{"key":"B97","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/IAI.05887-11","article-title":"Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development","volume":"80","year":"2012","journal-title":"Infect. Immun."},{"key":"B98","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","article-title":"New insights into malaria pathogenesis","volume":"15","year":"2020","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1473-3099(24)00752-7","article-title":"Safety and efficacy of the blood-stage malaria vaccine RH5.1\/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children","volume":"25","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"B100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chom.2014.06.004","article-title":"STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting","volume":"16","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B101","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1038\/s41598-017-13891-2","article-title":"An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies","volume":"7","year":"2017","journal-title":"Sci. Rep."},{"key":"B102","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei","volume":"216","year":"1967","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"crossref","first-page":"e4708","DOI":"10.1371\/journal.pone.0004708","article-title":"Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya","volume":"4","year":"2009","journal-title":"PLOS ONE"},{"key":"B104","doi-asserted-by":"crossref","first-page":"e43224","DOI":"10.7554\/eLife.43224","article-title":"Shed EBA-175 mediates red blood cell clustering that enhances malaria parasite growth and enables immune evasion","volume":"7","year":"2018","journal-title":"eLife"},{"key":"B105","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-023-40878-7","article-title":"Structure-based design of a strain transcending AMA1-RON2L malaria vaccine","volume":"14","year":"2023","journal-title":"Nat. Commun."},{"key":"B106","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-022-33336-3","article-title":"Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"B107","doi-asserted-by":"crossref","first-page":"101985","DOI":"10.1016\/j.xcrm.2025.101985","article-title":"A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade","volume":"6","year":"2025","journal-title":"Cell Rep. Med."},{"key":"B108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14760584.2021.1873135","article-title":"Structural vaccinology of malaria transmission-blocking vaccines","volume":"20","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"B109","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature23670","article-title":"Public antibodies to malaria antigens generated by two LAIR1 insertion modalities","volume":"548","year":"2017","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-022-28601-4","article-title":"Heterotypic interactions drive antibody synergy against a malaria vaccine candidate","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"B111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41586-020-2220-1","article-title":"Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria","volume":"582","year":"2020","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.str.2023.07.011","article-title":"Endothelial protein C receptor binding induces conformational changes to severe malaria-associated group A PfEMP1","volume":"31","year":"2023","journal-title":"Structure"},{"key":"B113","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/s41564-019-0462-1","article-title":"Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody","volume":"4","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-08220-3","article-title":"Broadly inhibitory antibodies to severe malaria virulence proteins","volume":"636","year":"2024","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2009.03.014","article-title":"A randomized controlled phase 2 trial of the blood stage AMA1-C1\/Alhydrogel malaria vaccine in children in Mali","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"B116","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature24994","article-title":"Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors","volume":"552","year":"2017","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41586-025-09091-y","article-title":"RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1","volume":"643","year":"2025","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2021.02.033","article-title":"Plasmodium falciparum RIFIN is a novel ligand for inhibitory immune receptor LILRB2","volume":"548","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B119","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41541-023-00709-8","article-title":"A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B120","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/vaccines12050546","article-title":"A self-assembling Pfs230D1-ferritin nanoparticle vaccine has potent and durable malaria transmission-reducing activity","volume":"12","year":"2024","journal-title":"Vaccines"},{"key":"B121","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.jmb.2019.05.018","article-title":"Blood-stage malaria parasite antigens: structure, function, and vaccine potential","volume":"431","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B122","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/EC.00060-07","article-title":"Plasmodium P25 and P28 surface proteins: potential transmission-blocking vaccines","volume":"6","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"B123","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","year":"2017","journal-title":"Nat. Commun."},{"key":"B124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20170869","article-title":"Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection","volume":"215","year":"2018","journal-title":"J. Exp. Med."},{"key":"B125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","article-title":"PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B126","first-page":"67","article-title":"A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice","volume":"11","year":"2026","journal-title":"Nat. Microbiol."},{"key":"B127","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41541-023-00712-z","article-title":"A human antibody epitope map of the malaria vaccine antigen Pfs25","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B128","doi-asserted-by":"crossref","first-page":"19556","DOI":"10.1038\/s41598-022-24054-3","article-title":"Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design","volume":"12","year":"2022","journal-title":"Sci. Rep."},{"key":"B129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pt.2024.10.017","article-title":"The Plasmodium circumsporozoite protein","volume":"40","year":"2024","journal-title":"Trends Parasitol"},{"key":"B130","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/IAI.01679-05","article-title":"Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity","volume":"74","year":"2006","journal-title":"Infect. Immun."},{"key":"B131","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1473-3099(19)30739-X","article-title":"PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study","volume":"20","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B132","doi-asserted-by":"crossref","first-page":"21420","DOI":"10.1073\/pnas.1218581109","article-title":"Shape change in the receptor for gliding motility in Plasmodium sporozoites","volume":"109","year":"2012","journal-title":"PNAS"},{"key":"B133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection","volume":"2","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B134","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1038\/s41598-021-90722-5","article-title":"Platelet derived growth factor receptor \u03b2 (PDGFR\u03b2) is a host receptor for the human malaria parasite adhesin TRAP","volume":"11","year":"2021","journal-title":"Sci. Rep."},{"key":"B135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)80511-5","article-title":"TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites","volume":"90","year":"1997","journal-title":"Cell"},{"key":"B136","first-page":"2ra5","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development","volume":"1","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"B137","doi-asserted-by":"crossref","first-page":"eabg2344","DOI":"10.1126\/scitranslmed.abg2344","article-title":"Functional human IgA targets a conserved site on malaria sporozoites","volume":"13","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature16450","article-title":"A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens","volume":"529","year":"2016","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm.4513","article-title":"A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein","volume":"24","year":"2018","journal-title":"Nat. Med."},{"key":"B140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.immuni.2023.01.012","article-title":"A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine","volume":"56","year":"2023","journal-title":"Immunity"},{"key":"B141","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1038\/s41467-024-51701-2","article-title":"Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"B142","doi-asserted-by":"crossref","first-page":"e20200061","DOI":"10.1084\/jem.20200061","article-title":"A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity","volume":"217","year":"2020","journal-title":"J. Exp. Med."},{"key":"B143","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"B144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/14760584.2023.2295430","article-title":"Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate","volume":"23","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"B145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cell.2005.05.033","article-title":"Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum","volume":"122","year":"2005","journal-title":"Cell"},{"key":"B146","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1126\/science.1204988","article-title":"Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide","volume":"333","year":"2011","journal-title":"Science"},{"key":"B147","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cit174","article-title":"An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection","volume":"57","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B148","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.str.2023.02.009","article-title":"Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope","volume":"31","year":"2023","journal-title":"Structure"},{"key":"B149","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41564-019-0461-2","article-title":"Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP","volume":"4","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B150","doi-asserted-by":"crossref","first-page":"e1000853","DOI":"10.1371\/journal.ppat.1000853","article-title":"Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility","volume":"6","year":"2010","journal-title":"PLOS Pathog"},{"key":"B151","doi-asserted-by":"crossref","first-page":"100867","DOI":"10.1016\/S2666-5247(24)00083-1","article-title":"R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18\u201345 years: an open-label, partially blinded, phase 1\u20132a controlled human malaria infection study","volume":"6","year":"2025","journal-title":"Lancet Microbe"},{"key":"B152","doi-asserted-by":"crossref","first-page":"1026052","DOI":"10.3389\/fimmu.2022.1026052","article-title":"Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS","volume":"13","year":"2022","journal-title":"Front. Immunol"},{"key":"B153","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro.2017.47","article-title":"Variant surface antigens of Plasmodium falciparum and their roles in severe malaria","volume":"15","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B154","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1016\/j.cell.2024.06.037","article-title":"Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5","volume":"187","year":"2024","journal-title":"Cell"},{"key":"B155","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41590-024-01938-2","article-title":"Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention","volume":"25","year":"2024","journal-title":"Nat. Immunol."},{"key":"B156","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","article-title":"A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver","volume":"53","year":"2020","journal-title":"Immunity"},{"key":"B157","doi-asserted-by":"crossref","first-page":"e1004670","DOI":"10.1371\/journal.ppat.1004670","article-title":"Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes","volume":"11","year":"2015","journal-title":"PLOS Pathog"},{"key":"B158","volume-title":"World malaria report 2025","year":"2025"},{"key":"B159","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41541-022-00480-2","article-title":"Anti-TRAP\/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies","volume":"7","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B160","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41467-024-48721-3","article-title":"Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"B161","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-023-02659-z","article-title":"A candidate antibody drug for prevention of malaria","volume":"30","year":"2024","journal-title":"Nat. Med."},{"key":"B162","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.1038\/s41467-024-53848-4","article-title":"Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"B163","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/IAI.74.2.1313-1322.2006","article-title":"Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum","volume":"74","year":"2006","journal-title":"Infect. Immun."},{"key":"B164","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","year":"2014","journal-title":"Nature"},{"key":"B165","doi-asserted-by":"crossref","first-page":"109600","DOI":"10.1016\/j.celrep.2021.109600","article-title":"Structural basis of malarial parasite RIFIN-mediated immune escape against LAIR1","volume":"36","year":"2021","journal-title":"Cell Rep"},{"key":"B166","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41467-021-24291-6","article-title":"Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs","volume":"12","year":"2021","journal-title":"Nat. Commun."},{"key":"B167","doi-asserted-by":"crossref","first-page":"e12745","DOI":"10.1111\/cmi.12745","article-title":"AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver","volume":"19","year":"2017","journal-title":"Cell. Microbiol."}],"container-title":["Annual Review of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-micro-042424-032639?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:57:00Z","timestamp":1792810620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-micro-042424-032639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,10,23]]}},"URL":"https:\/\/doi.org\/10.1146\/annurev-micro-042424-032639","relation":{},"ISSN":["0066-4227","1545-3251"],"issn-type":[{"value":"0066-4227","type":"print"},{"value":"1545-3251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]}}}